의료용 빅데이터 시장 : 예측(-2032년) - 컴포넌트별, 데이터 유형별, 전개 방식별, 용도별, 최종사용자별, 지역별 분석

According to Stratistics MRC, the Global Big Data in Healthcare Market is accounted for $57.54 billion in 2025 and is expected to reach $138.85 billion by 2032 growing at a CAGR of 13.41% during the forecast period. Big Data in healthcare refers to the vast and complex collection of health-related information generated from various sources such as electronic health records (EHRs), medical imaging, genomic sequencing, wearable devices, and patient feedback. This data is analyzed using advanced analytics, artificial intelligence, and machine learning techniques to uncover patterns, improve clinical decision-making, enhance patient outcomes, and reduce healthcare costs. By integrating and interpreting diverse data sets, Big Data enables personalized medicine, predictive diagnostics, and efficient management of healthcare resources and population health trends.

Market Dynamics:

Driver:

Improved clinical outcomes & personalized medicine

Hospitals and research institutions are investing in platforms that support real-time analytics, predictive modeling, and clinical benchmarking. Integration with electronic health records, imaging systems, and genomic databases is enhancing care personalization. Vendors are developing tools that align with value-based care and population health strategies. Regulatory bodies are supporting data standardization to improve interoperability and transparency. The market is evolving toward precision medicine powered by advanced analytics.

Restraint:

Data privacy & cybersecurity risk

Data privacy and cybersecurity risk is prompting caution among providers, insurers, and regulators. Breach incidents and compliance failures can result in reputational damage and legal penalties. Organizations must invest in encryption, access control, and audit mechanisms to meet HIPAA and GDPR standards. Legacy systems and fragmented data architectures complicate protection efforts. These challenges are slowing adoption of cloud-based and cross-institutional analytics platforms.

Opportunity:

Advances in AI, cloud and analytics technology

Advances in AI, cloud, and analytics technology are enabling faster insights from structured and unstructured datasets. Hospitals are deploying machine learning models to support diagnostics, triage, and operational efficiency. Cloud platforms are improving scalability and access to real-time data across distributed networks. Integration with wearable devices and remote monitoring tools is enhancing longitudinal patient tracking. This momentum is unlocking new possibilities in preventive and personalized care.

Threat:

Poor data quality and governance

Poor data quality and governance is affecting model accuracy, compliance, and decision-making. Incomplete records, inconsistent formats, and outdated entries degrade analytical outcomes. Organizations must implement robust data stewardship frameworks to ensure validity and traceability. Lack of standardized protocols across institutions is complicating interoperability and benchmarking. These risks are prompting investment in quality assurance and metadata management.

Covid-19 Impact:

The pandemic accelerated digital health adoption and highlighted the value of real-time data in crisis response. Hospitals and governments relied on big data platforms to track infection rates, allocate resources, and model outbreak scenarios. Remote care and telehealth surged, generating new data streams for analysis. Investment in cloud infrastructure and AI tools increased to support pandemic preparedness and recovery. Public-private partnerships emerged to improve data sharing and epidemiological modeling. The crisis permanently elevated big data from operational support to strategic infrastructure.

The software & platforms segment is expected to be the largest during the forecast period

The software & platforms segment is expected to account for the largest market share during the forecast period due to their central role in data aggregation, analysis, and visualization. Vendors are offering modular solutions that integrate with EHRs, imaging systems, and genomic databases. Cloud-native architecture and AI-powered analytics are improving scalability and insight generation. Hospitals and research centers are adopting platforms that support clinical decision-making and operational optimization. Demand for real-time dashboards and predictive tools are rising across care settings. This segment anchors the digital transformation of healthcare analytics.

The genomic data segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the genomic data segment is predicted to witness the highest growth rate as precision medicine and genetic research gain momentum. Sequencing technologies are generating vast datasets that require advanced analytics for interpretation. Integration with clinical records and phenotype data is improving disease risk assessment and treatment planning. Vendors are developing platforms that support variant analysis, biomarker discovery, and personalized therapy design. Partnerships between biotech firms and healthcare providers are accelerating adoption.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its advanced healthcare infrastructure, regulatory clarity, and innovation ecosystem. The United States and Canada are scaling big data adoption across hospitals, research institutions, and public health agencies. Investment in AI, cloud platforms, and interoperability standards is driving platform deployment. Presence of leading vendors and academic centers is reinforcing market strength. Government initiatives such as HITECH and 21st Century Cures Act are supporting data integration and analytics.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as healthcare access, digital infrastructure, and research investment expand. Countries like China, India, Japan, and South Korea are scaling big data platforms across hospitals, diagnostics labs, and genomics centers. Government-backed health digitization programs and startup ecosystems are accelerating innovation. Mobile health adoption and wearable integration are generating new data streams for analysis. Regional providers are investing in cloud-based and AI-enabled tools to improve care delivery.

Key players in the market

Some of the key players in Big Data in Healthcare Market include IBM Watson Health, Google Health, Amazon Web Services (AWS), Oracle Corporation, Microsoft Azure for Healthcare, SAS Institute Inc., Optum, Cerner Corporation, Epic Systems Corporation, GE Healthcare, Siemens Healthineers, Health Catalyst, Palantir Technologies Inc., Flatiron Health and Truven Health Analytics.

Key Developments:

In September 2025, AWS introduced ready-to-deploy templates for HIPAA-compliant environments, healthcare data lakes, and clinical analytics platforms. These solutions were designed to modernize healthcare data platforms, enabling organizations to leverage generative AI and big data analytics for improved patient outcomes.

In March 2024, Google Health partnered with HCA Healthcare to implement generative AI tools aimed at reducing administrative burdens in emergency departments. These tools assisted in documenting patient visits and streamlining nurse handoffs, thereby enhancing clinical efficiency and allowing healthcare professionals to focus more on patient care.

In June 2022, Francisco Partners completed the acquisition of IBM's healthcare data division, including Health Insights, MarketScan, Micromedex, and Merge Imaging. The deal led to the formation of Merative, a standalone company focused on healthcare analytics, clinical development, and decision support.

Components Covered:

• Software & Platforms
• Services

Data Types Covered:

• Clinical Data
• Genomic Data
• Imaging Data
• Patient-Generated Health Data
• Claims & Billing Data
• Wearable & Sensor Data

Deployment Modes Covered:

• On-Premise
• Cloud-Based
• Hybrid

Applications Covered:

• Population Health Management
• Clinical Decision Support
• Precision Medicine & Genomics
• Remote Patient Monitoring
• Fraud Detection & Risk Management
• Other Applications

End Users Covered:

• Pharmaceutical & Biotech Companies
• Payers & Insurance Firms
• Research Institutes
• Government & Public Health Agencies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Big Data in Healthcare Market, By Component

• 5.1 Introduction
• 5.2 Software & Platforms
  • 5.2.1 Data Integration Tools
  • 5.2.2 Predictive Analytics Platforms
  • 5.2.3 Visualization & Dashboard Tools
• 5.3 Services
  • 5.3.1 Consulting & Implementation
  • 5.3.2 Managed Services
  • 5.3.3 Data Governance & Compliance

6 Global Big Data in Healthcare Market, By Data Type

• 6.1 Introduction
• 6.2 Clinical Data
• 6.3 Genomic Data
• 6.4 Imaging Data
• 6.5 Patient-Generated Health Data
• 6.6 Claims & Billing Data
• 6.7 Wearable & Sensor Data

7 Global Big Data in Healthcare Market, By Deployment Mode

• 7.1 Introduction
• 7.2 On-Premise
• 7.3 Cloud-Based
• 7.4 Hybrid

8 Global Big Data in Healthcare Market, By Application

• 8.1 Introduction
• 8.2 Population Health Management
• 8.3 Clinical Decision Support
• 8.4 Precision Medicine & Genomics
• 8.5 Remote Patient Monitoring
• 8.6 Fraud Detection & Risk Management
• 8.7 Other Applications

9 Global Big Data in Healthcare Market, By End User

• 9.1 Introduction
• 9.2 Pharmaceutical & Biotech Companies
• 9.3 Payers & Insurance Firms
• 9.4 Research Institutes
• 9.5 Government & Public Health Agencies
• 9.6 Other End Users

10 Global Big Data in Healthcare Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 IBM Watson Health
• 12.2 Google Health
• 12.3 Amazon Web Services (AWS)
• 12.4 Oracle Corporation
• 12.5 Microsoft Azure for Healthcare
• 12.6 SAS Institute Inc.
• 12.7 Optum
• 12.8 Cerner Corporation
• 12.9 Epic Systems Corporation
• 12.10 GE Healthcare
• 12.11 Siemens Healthineers
• 12.12 Health Catalyst
• 12.13 Palantir Technologies Inc.
• 12.14 Flatiron Health
• 12.15 Truven Health Analytics